Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero and HER2-low breast cancer.
Kang S, Lee SH, Lee HJ, Jeong H, Jeong JH, Kim JE, Ahn JH, Jung KH, Gong G, Kim HH, Lee S, Lee J, Kim SB.
Kang S, et al. Among authors: kim sb, kim hh, kim je.
Eur J Cancer. 2023 Sep;191:112956. doi: 10.1016/j.ejca.2023.112956. Epub 2023 Jun 24.
Eur J Cancer. 2023.
PMID: 37473465
Free article.